Connect with us

Life Sciences

Getting Started with mRNA–Increasing your Probability for Success

This webinar, sponsored by TriLink, will provide a timely introduction to the world of mRNA-based therapeutics, encompassing their design, synthesis, modifications,…

Published

on

This article was originally published by GEN Genetic Engineering and Biotechnology News

Broadcast Date: September 18, 2023
Time: 8:00 am PT, 11:00 am ET, 17:00 CET

The emergence of mRNA as a versatile platform for therapeutic and vaccine development holds immense promise in reshaping the landscape of molecular medicine. As researchers and biopharmaceutical professionals explore the potential of mRNA-based technologies, a comprehensive understanding of the fundamental principles, techniques, and past insights becomes essential for achieving successful outcomes.

This webinar will provide a timely introduction to the world of mRNA-based therapeutics, encompassing their design, synthesis, modifications, and applications. A deeper dive into the optimization of mRNA design and in vitro transcription processes will unveil strategies for streamlining mRNA manufacturing. Whether you’re new to mRNA research or seeking to enhance your existing knowledge, this webinar will equip you with the tools and insights needed to accelerate your journey toward successful mRNA-based projects.

Learning objectives:

  • Understand how optimal mRNA construct design can help streamline mRNA manufacturing
  • Explore the utilization of modified bases to reduce the innate immune response and improve mRNA activity
  • Recognize the importance of characterizing mRNA early in the drug development process
  • Delve into next-generation capping strategies to increase mRNA potency

 

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.

 

Produced with support from:

TriLink Biotechnologies logo
Jordana Henderson
Jordana Henderson
Associate Director of Technical Design
TriLink Biotechnologies

The post Getting Started with mRNA–Increasing your Probability for Success appeared first on GEN – Genetic Engineering and Biotechnology News.



Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending